enzyme-AMFA therapy (NanoMedSyn/Takeda)

N/A

Report date: 2025/03/20 15:27:29

Base Information

Drug Nameenzyme-AMFA therapy (NanoMedSyn/Takeda)
Drug Alias Nameenzyme-AMFA therapy (NanoMedSyn/Shire)
ClassificationBiologics
Mechanisms of ActionInsulin-like growth factor II receptor modulatorsMaltase-glucoamylase stimulants
TargetsInsulin-like growth factor II receptorMaltase-glucoamylase
Therapy Area/IndicationsLysosomal acid lipase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoMedSyn
China Registration ClassN/A

Develop Information

Active CompaniesNanoMedSynTakeda Pharmaceutical Co Ltd
Inactive CompaniesShire
Active IndicationsLysosomal acid lipase deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A